2019 · Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · paywalled
A patient-centric liquid chromatography-tandem mass spectrometry microsampling assay for analysis of cannabinoids in human whole blood: Application to pediatric pharmacokinetic study
Moorthy et al.
The finding, in our words
The authors developed and validated an LC-MS/MS assay for THC, CBD and CBN from 20 µL VAMS blood samples with linear calibration curves and inter-day accuracies of 94.4 to 107 per cent, then applied it to a pediatric pharmacokinetic study, demonstrating that patient-centric microsampling can support decentralised therapeutic drug monitoring of cannabinoids in children.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.